LINE Quote, Financials, Valuation and Earnings

Broadstone Net Lease, Inc. has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 23.55%. Lineage, Inc.'s return on equity of -2.03% beat Broadstone Net Lease, Inc.'s return on equity of 2.99%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 4.24%. On the other hand Broadstone Net Lease, Inc. has an analysts' consensus of $20.18 which suggests that it could grow by 4.25%. Given that Broadstone Net Lease, Inc. has higher upside potential than Lineage, Inc., analysts believe Broadstone Net Lease, Inc. is more attractive than Lineage, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Broadstone Net Lease, Inc. has a beta of 0.998, suggesting its less volatile than the S&P 500 by 0.223%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.58%. Broadstone Net Lease, Inc. offers a yield of 3.82% to investors and pays a quarterly dividend of $0.29 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Broadstone Net Lease, Inc. pays out 134.52% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Broadstone Net Lease, Inc.'s is not.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Broadstone Net Lease, Inc. quarterly revenues of $114.9M. Lineage, Inc.'s net income of -$112M is lower than Broadstone Net Lease, Inc.'s net income of $27.1M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Broadstone Net Lease, Inc.'s PE ratio is 41.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.61x versus 8.43x for Broadstone Net Lease, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Centerspace has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 43.34%. Lineage, Inc.'s return on equity of -2.03% beat Centerspace's return on equity of 4.38%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 4.24%. On the other hand Centerspace has an analysts' consensus of $68.39 which suggests that it could grow by 8.95%. Given that Centerspace has higher upside potential than Lineage, Inc., analysts believe Centerspace is more attractive than Lineage, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centerspace has a beta of 0.779, suggesting its less volatile than the S&P 500 by 22.096%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.58%. Centerspace offers a yield of 4.91% to investors and pays a quarterly dividend of $0.77 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Centerspace pays out 361.12% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Centerspace's is not.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Centerspace quarterly revenues of $150.9M. Lineage, Inc.'s net income of -$112M is lower than Centerspace's net income of $65.4M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Centerspace's PE ratio is 47.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.61x versus 3.10x for Centerspace. Usually stocks with elevated PS ratios are considered overvalued.

Peakstone Realty Trust has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 68.74%. Lineage, Inc.'s return on equity of -2.03% beat Peakstone Realty Trust's return on equity of -31.39%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 4.24%. On the other hand Peakstone Realty Trust has an analysts' consensus of $21.00 which suggests that it could grow by 0.91%. Given that Lineage, Inc. has higher upside potential than Peakstone Realty Trust, analysts believe Lineage, Inc. is more attractive than Peakstone Realty Trust.

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Peakstone Realty Trust has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.58%. Peakstone Realty Trust offers a yield of 3.12% to investors and pays a quarterly dividend of $0.10 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Peakstone Realty Trust pays out 291.09% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Peakstone Realty Trust's is not.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Peakstone Realty Trust quarterly revenues of $25.8M. Lineage, Inc.'s net income of -$112M is lower than Peakstone Realty Trust's net income of $17.7M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Peakstone Realty Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.61x versus 3.92x for Peakstone Realty Trust. Usually stocks with elevated PS ratios are considered overvalued.

Symmetry Medical, Inc. has a net margin of -8.13% compared to Lineage, Inc.'s net margin of --. Lineage, Inc.'s return on equity of -2.03% beat Symmetry Medical, Inc.'s return on equity of --.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 4.24%. On the other hand Symmetry Medical, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Lineage, Inc. has higher upside potential than Symmetry Medical, Inc., analysts believe Lineage, Inc. is more attractive than Symmetry Medical, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Symmetry Medical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.58%. Symmetry Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Symmetry Medical, Inc. pays out -- of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Symmetry Medical, Inc. quarterly revenues of --. Lineage, Inc.'s net income of -$112M is higher than Symmetry Medical, Inc.'s net income of --. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Symmetry Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.61x versus -- for Symmetry Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.